Baxter Halts Production Of Multidose Heparin Vials
The drugmaker's announcement came just weeks after it recalled nine lots of the injectable blood thinner that nearly killed actor Dennis Quaid's newborn twins. Although it is halting production of heparin, however, Baxter will continue distributing the medication.
The U.S. Food and Drug Administration said it supported Baxter's plan of action.
To view the full article, register now.